¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"invisible differentiation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® differentiation ÇÑ±Û ºÐÈ­
¼³¸í   
  ¼¼Æ÷°¡ ºÐ¿­, Áõ½ÄÇÏ¿© ¼ºÀåÇϴ µ¿¾È¿¡ ±¸Á¶³ª ±â´ÉÀÌ ¼­·Î Æ¯¼öÈ­Çϴ Çö»ó. ´Ù¼¼Æ÷»ý¹° °³Ã¼¿¡¼­ ±â°üÀ̳ª Á¶Á÷À̳ª ¼¼Æ÷°£¿¡ ÇüÅÂÀû ¹× ±â´ÉÀû Â÷À̰¡ »ý±â°Ô µÇ´Âµ¥, ¿¹¸¦ µé¸é °³Ã¼¹ß»ý¿¡¼­ Ã³À½¿¡´Â µ¿ÁúÀ̾ú´ø ºÎºÐ¿¡¼­ ¸Ó¸®³ª ¸öÅë µîÀÇ ±¸º°ÀÌ »ý±â°í, ¼¼Æ÷¿¡¼­µµ ±Ù¼¼Æ÷, ½Å°æ¼¼Æ÷ µîÀÇ ±¸º°ÀÌ »ý±â´Â »óŸ¦ ¸»ÇÑ´Ù. ÀϹÝÀûÀ¸·Î ºÐÈ­ÇÑ ¼¼Æ÷¿¡¼­´Â ÇüÅÂÀû Æ¯¼öÈ­¿Í ´õºÒ¾î ºÐÈ­ÀÇ ÁöÇ¥°¡ µÇ´Â Æ¯ÀÌÇÑ ´Ü¹éÁú ÇÕ¼ºÀÌ ³ªÅ¸³ª±â ¶§¹®¿¡ ºÐÈ­´Â À¯ÀüÀÚÀÇ Á¶Àý¿¡ ÀÇÇØ ³ªÅ¸³­ °á°ú¶ó°í »ý°¢µÇ°í ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • invisible ray
    ºÒ°¡½Ã±¤¼±
  • cluster of differentiation
    ºÐÈ­¹«¸®, ½Ãµð(CD)
  • differentiation
    ºÐÈ­
  • differentiation defect
    ºÐÈ­°áÇÔ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • differentiation
    ºÐÈ­
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • invisible ray
    ºÒ°¡½Ã±¤¼±
  • differentiation
    ºÐÈ­
  • differentiation defect
    ºÐÈ­°áÇÔ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • B cell differentiation factor (BCDF)
    B¼¼Æ÷ ºÐÈ­À¯¹ßÀÎÀÚ
  • T-cell differentiation
    T-¼¼Æ÷ºÐÈ­
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • invisible ray
    ºÒ°¡½Ã±¤¼±.
  • cell differentiation
    ¼¼Æ÷ºÐÈ­(¡­ÝÂûù)
  • cell differentiation
    ¼¼Æ÷ºÐÈ­(¡­ÝÂûù).
  • differentiation
    °¨º°(Êüܬ), ºÐÈ­(ÝÂûù), ºÐº°(ÝÂܬ)
  • differentiation
    °¨º°(Êüܬ), ºÐÈ­(ÝÂûù), ºÐº°(ÝÂܬ).
  • differentiation
    ºÐÈ­
  • differentiation antigen
    °¨º°Ç׿ø(Êüܬù÷ê«)
  • differentiation defect
    ºÐÈ­°áÇÔ
  • differentiation factor
    °¨º°¿äÀÎ, °¨º°¿ä¼Ò, °¨º°ÀÎÀÚ
  • differentiation zone
    ºÐÈ­±¸¿ª
  • epidermal differentiation
    Ç¥ÇǺÐÈ­
  • lymphoid system differentiation
    ¸²ÇÁ°èºÐÈ­
  • regional differentiation
    ºÎÀ§Àû ºÐÈ­(Ý»êÈîÜÝÂûù)
  • sex differentiation
    ¼ººÐÈ­.
  • sexual differentiation
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Differentiation
    ºÐÈ­
    [¿¾ ¿ë¾î] ºÐÈ­
  • Differentiation defect
    ºÐÈ­°áÇÔ
    [¿¾ ¿ë¾î] ºÐÈ­°áÇÔ
  • Differentiation zone
    ºÐÈ­±¸¿ª
    [¿¾ ¿ë¾î] ºÐÈ­´ë
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cell differentiation
    ¼¼Æ÷ºÐÈ­(á¬øàÝÂûù)
  • differentiation
    ºÐÈ­(ÝÂûù)
  • differentiation antigen
    ºÐÈ­ Ç׿ø(ÝÂûùù÷ê«)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • differentiation
    °¨º°, ÁØÈ­, ºÐº°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AML Acute Myelogenous Leukemia
  Morphologic Classification(FABºÐ·ù)
   &n...
EDF eosinophil differentiation factor; erythroid differentiation factor; extradural fluid
CD Cluster of differentiation
ADRP adipose differentiation-related protein
BCDF B-cell differentiation factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EDF A/erythroid differentiation factor
ADRP Adipose differentiation related protein
BCDF B cell differentiation factor
CD Cluster of Differentiation
CMD Corticomedullary differentiation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • invisible
    ºÒ°¡½ÃÀÇ
  • cell differentiation
    ¼¼Æ÷ ºÐÈ­
    ¼¼Æ÷µéÀÌ Á¶Á÷ÀÇ ´Ù¾çÇÑ ±âº» ¼¼Æ÷ ´ÜÀ§·Î ¼ºÀåÇÏ´Â °Í. »óÇǼ¼Æ÷, ½Å°æ¼¼Æ÷
  • differentiation antigen
    ºÐÈ­ Ç׿ø
    ¼¼Æ÷°¡ ºÐÈ­ÇØ °¡´Âµ¥ À־ Ç¥ÇöµÇ´Â ¼¼Æ÷¸· »óÀÇ Ç׿ø. T ¼¼Æ÷¿¡¼­´Â B ¼¼Æ÷·ÎºÎÅÍ ±¸º°ÇÏ´Â ºÐÈ­ Ç׿øÀº mouse »çÀÌ¿¡¼­ ¼¼Æ÷¸¦ Åõ¿©ÇÏ¿© ¸¸µé¾îÁø µ¿Á¾ Ç×Ç÷û¿¡ ÀÇÇÏ¿© °ËÃâµÇ´Â Ç׿ø
  • differentiation factor
    °¨º° ¿äÀÎ, °¨º° ¿ä¼Ò, °¨º° ÀÎÀÚ
  • sex differentiation
    ¼º ºÐÈ­
  • squamous differentiation
    ÆíÆò »óÇÇ·ÎÀÇ ºÐÈ­
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
invisible differentiation Differentiation of the cellular chemical constituents in the embryo prior to cytodifferentiation; sometimes recognizable histochemically.
Synonym: invisible differentiation.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
invisible Incapable of being seen; not perceptible by vision; not visible. "To us invisible, or dimly seen In these thy lowest works.
<zoology> " (Milton) Invisible bird, a small, shy singing bird (Myadestes sibilons), of St. Vincent Islands. Invisible green, a very dark shade of green, approaching to black, and liable to be mistaken for it.
Origin: F. Invisible, L. Invisibilis. See In- not, and Visible.
Source: Websters Dictionary
(01 Mar 1998)
invisible spectrum The radiation lying on either side of visible light, i.e., infrared and ultraviolet light.
(05 Mar 2000)
antigens, differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation.
(12 Dec 1998)
antigens, differentiation, b-lymphocyte Membrane antigens associated with maturation stages of B-lymphocytes, often expressed in tumours of B-cell origin.
(12 Dec 1998)
antigens, differentiation, myelomonocytic Surface antigens expressed on myeloid cells of the granulocyte-monocyte-histiocyte series during differentiation. Analysis of their reactivity in normal and malignant myelomonocytic cells is useful in identifying and classifying human leukaemias and lymphomas.
(12 Dec 1998)
antigens, differentiation, t-lymphocyte Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function.
(12 Dec 1998)
B-cell differentiation/growth factors Various substances, usually obtained from the supernatant of T-cell cultures, such as interleukin 4, 5, and 6. These substances are necessary for B-cell growth, maturation, and differentiation into plasma cells or B memory cells.
(05 Mar 2000)
cell differentiation Progressive restriction of the developmental potential and increasing specialization of function which takes place during the development of the embryo and leads to the formation of specialised cells, tissues, and organs.
(12 Dec 1998)
cluster of differentiation Cell membrane molecules that are used to classify leukocytes into subsets. CD molecules are classified by monoclonal antibodies.
(05 Mar 2000)
cluster of differentiation 2 A glycoprotein that is expressed on all peripheral T-cells, large granular lymphocytes and most, but not all, thymocytes. CD2 is involved in signal transduction and cell adhesion.
(05 Mar 2000)
cluster of differentiation 3 A complex of 5 polypeptides associated with the T-cell receptor and is involved in signal transduction.
(05 Mar 2000)
cluster of differentiation 4 A glycoprotein found on various subsets of T-cells, i.e., usually no helper and some T cytotoxic cells.
(05 Mar 2000)
cluster of differentiation 8 Membrane glycoprotein found on subsets of T lymphocytes. CD8 is expressed on T cytotoxic cells and T suppressor cells.
Acronym: CD
(05 Mar 2000)
correlative differentiation Differentiation due to the interaction of different parts of an organism.
(05 Mar 2000)
self-differentiation Differentiation resulting from the action of intrinsic causes.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • differentiation
    ±¸º°;ºÐÈ­;º¯ÀÌ;Ư¼öÈ­;¹ÌºÐ
  • invisible
    ´«¿¡ º¸ÀÌÁö ¾Ê´Â
  • church invisible
    º¸ÀÌÁö ¾Ê´Â ±³È¸;Àçõ ±³È¸
  • invisible
    ´«¿¡ ¾Èº¸ÀÌ´Â;¾ó±¼À» º¸ÀÌÁö ¾Ê´Â;¸ð½ÀÀ» ³ªÅ¸³»Áö ¾Ê´Â;¿µ°è;½Å
  • invisible balance
    (°æ)¹«¿ª¿Ü ¼öÁö)
  • invisible cap
    ¿ä¼ú¸ðÀÚ(À̰ÍÀ» ¾²¸é ³²ÀÇ ´«¿¡ º¸ÀÌÁö ¾Ê°Ô µÈ´Ù´Â Àü¼³ÀÇ)
  • invisible exports
    ¹«¿ªÀÇ ¼öÃâ;¹«Çü¼öÃâǰ(ƯÇã·á,¿Ü±¹Ç° ¼ö¼Û·á,º¸Çè·áµî)
  • invisible glass
    ºÒ°¡½ÃÀ¯¸®;¹«¹Ý»çÀ¯¸®
  • invisible government
    (¹Ì)º¸ÀÌÁö ¾Ê´Â Á¤ºÎ(CIA)ÀÇ º°Äª
  • invisible green
    (°ËÁ¤Ã³·³ º¸ÀÌ´Â)£Àº ÃÊ·Ï»ö
  • invisible hand
    (°æ)º¸ÀÌÁö ¾Ê´Â ¼Õ;(Adam SmithÀÇ °æÁ¦Çп¡¼­)
  • invisible imports
    ¹«¿ª¿Ü ¼öÀÔ;¹«Çü¼öÀÔǰ(cf.INVISIBLE EXPORTS)
  • invisible ink
    SECRET INK
  • invisible mending
    ÀÚ±¹ÀÌ ³²Áö ¾Ê°Ô ¼ö¸®Çϱâ;Â¥±é±â
  • invisible trade
    ¹«¿ª¿Ü °Å·¡;¹«Çü ¹«¿ª(°ü±¤,º¸Çè,¿îÀÓµî)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á